Stocksigma LogoStocksigma Logo

Nephrocare Health Services Approves Grant of 38,236 Options Under ESOP 2026

Nephrocare Health Services Limited announced that its Nomination and Remuneration Committee approved the grant of 38,236 Employee Stock Options under the

Nephrocare Health Services Approves Grant of 38,236 Options Under ESOP 2026

Nephrocare Health Services Ltd · Others (Uncategorized) · 17 Nov 2026, 11:11 pm

Nephrocare Health Services Approves Grant of 38,236 Options Under ESOP 2026 Nephrocare Health Services Limited announced that its Nomination and Remuneration Committee approved the grant of 38,236 Employee Stock Options under the NephroPlus Employee Stock Option Scheme, 2026 via circular resolution on 17th Nov'26. Each option is convertible into one equity share of face value ₹2 at an exercise price of ₹513.60 per option. The options carry a minimum vesting period of one year from the grant date and can be exercised within a maximum period of five years from each respective vesting date.

Original exchange filing (PDF)

More announcements from Nephrocare Health Services Ltd

All Nephrocare Health Services Ltd announcements